Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women.

Thirty women were randomized in a double-blind, placebo-controlled study to receive either norfloxacin, 200 mg orally daily at bedtime, or placebo for the prevention of recurrent bladder infection. Subjects were followed monthly to monitor compliance and symptoms, for urine culture and periurethral...

Description complète

Détails bibliographiques

Publié dans:	Antimicrob Agents Chemother
Auteurs principaux:	Nicolle, L E, Harding, G K, Thompson, M, Kennedy, J, Urias, B, Ronald, A R
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1989
Sujets:	Research Article
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176057/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2675752/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.7.1032
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!